Theravance Respiratory Company, LLC - Summary financial information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Summary financial information
Current assets	$ 154,729		$ 154,729		$ 249,870
Current liabilities	32,624		32,624		$ 58,587
Revenues	11,050	$ 12,914	24,246	$ 27,171
Net income	(8,191)	(52,405)	(34,137)	(132,084)
TRC
Summary financial information
Income from continuing operations	42,581	26,050	71,693	44,853
Net income	$ 33,091	25,796	$ 62,632	44,116
Percentage of equity interest	85.00%		85.00%
TRC | Royalties
Summary financial information
Revenues	$ 42,720	$ 26,386	$ 72,029	$ 48,470